Resultados de procura - Kristin Gurtner

  • Mostrando 1 - 5 Resultados de 5
Limitar resultados
  1. 1
    β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy

    β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy por Iris Eke, Yvonne Deuse, Stephanie Hehlgans, Kristin Gurtner, Mechthild Krause, Michaël Baumann, Anna Shevchenko, Veit Sandfort, Nils Cordes

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

    BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human... por L. Helbig, Lydia Koi, Kerstin Brüchner, Kristin Gurtner, Holger Hess‐Stumpp, Kerstin Unterschemmann, Michaël Baumann, Daniel Zips, Ala Yaromina

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Radioresistance of KRAS/TP53‐mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition <i>in vivo</i>

    Radioresistance of KRAS/TP53‐mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition <i>in vivo</i> por Kristin Gurtner, Zofia Kryzmien, Lydia Koi, Meng Wang, Cyril H. Benes, Sandra Hering, Henning Willers, Michaël Baumann, Mechthild Krause

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway

    Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway por Meng Wang, Jing Han, Lynnette Marcar, Joshua C. Black, Qi Liu, Xiangyong Li, Kshithija Nagulapalli, Lecia V. Sequist, Raymond H. Mak, Cyril H. Benes, Theodore S. Hong, Kristin Gurtner, Mechthild Krause, Michaël Baumann, Jing X. Kang, Johnathan R. Whetstine, Henning Willers

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Patterns of proton therapy use in pediatric cancer management in 2016: An international survey

    Patterns of proton therapy use in pediatric cancer management in 2016: An international survey por Neige Journy, Daniel J. Indelicato, Diana R. Withrow, Tetsuo Akimoto, Claire Alapetite, Masayuki Araya, Andrew L. Chang, John Chang, Brian H. Chon, Michael Confer, Yusuke Demizu, R. Dendale, J. Doyen, Ralph Ermoian, Kristin Gurtner, Christine E. Hill‐Kayser, Hiromitsu Iwata, Joo‐Young Kim, Young Kwok, Nadia N. Laack, Choonsik Lee, Do Hoon Lim, Lilia Loredo, V.S. Mangona, David B. Mansur, Masao Murakami, Shigeyuki Murayama, Takashi Ogino, Barbora Ondrová, Rahul R. Parikh, Arnold C. Paulino, Stephanie M. Perkins, Naren Ramakrishna, Ronald Richter, Barbara Rombi, Satoshi Shibata, Shinichi Shimizu, Beate Timmermann, T.Z. Vern-Gross, Chiachien J. Wang, Damien C. Weber, J. Ben Wilkinson, Petra Witt Nyström, Torunn I. Yock, Ruth A. Kleinerman, Amy Berrington de González

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: